Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise

Innovative, cloud-based digital platform supports Urologists’ access to enhanced training with the UroLift® System through remote collaboration tools

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it is combining its leading industry clinical education with the digital platform of Explorer Surgical, a GHX company. This collaboration will provide Urologists expanded access to interactive training and remote learning opportunities for the Teleflex UroLift®System. 

The Explorer Live cloud-based digital platform communicates critical information through an interactive digital playbook, enabling surgical teams to access customized information for specific team roles. The platform facilitates UroLift System trainer collaboration with Urology surgical teams during live procedures from anywhere in the country through remote video connectivity. 
“Our clinical teams are able to reinforce the best practices and techniques for the UroLift System, and ultimately help clinicians become more proficient with the device so they can achieve better patient outcomes,” said Kevin Hardage, President and General Manager of Interventional Urology at Teleflex. “This innovative platform makes it easy for us to provide support where and when it is needed.” 
“We have seen a tremendous response to Explorer Live from both our teams out in the field and the medical community they serve. And we are excited to offer physicians high-quality remote learning opportunities that can increase BPH patient access to effective treatment with the UroLift System,” said  Dale Zunke, Director of Clinical Affairs at Teleflex. 
“We are pleased to support Teleflex in its commitment to achieving the best outcomes for patients,” said Jennifer Fried, general manager, Explorer Surgical, a GHX company. “This is an exciting opportunity  for us to showcase how useful the platform can be in the urology specialty and demonstrate the need  for innovative workflow and case support tools.” 
With Explorer Live, all the processes and workflows of the UroLift System procedure are accessible before a surgical team performs any procedure. Through the platform, surgeons can: 
  • Access images, PDFs, and videos about the UroLift System, surgical techniques, and a step-by-step workflow for each team member. The digital playbook is customized to the clinical team’s role, procedure type, and surgeon preferences. 
  • Broadcast in real-time to provide clinical education, remote collaboration, or demonstrations. 
  • Capture robust video and procedural data to be used by the surgeon or in partnership with a  medical device company for performance tracking, identifying opportunities to reduce variability, post-market feedback and analysis, and future product development.  
The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It can result in rapid relief and recovery for men living with symptoms of an enlarged prostate,1 and provides an alternative therapy with a risk profile better than reported for surgical procedures such as TURP.2 The UroLift permanent implants are delivered during an outpatient procedure and relieve prostate obstruction without cutting, heating, or removing prostate tissue.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.